Comprehensive cancer control-research & development: Knowing what we do and doing what we know

Jon F. Kerner, Eduardo Cazap, Derek Yach, Marco A. Pierotti, Maria Grazia Daidone, Pasquale De Blasio, Peter Geary, Brent Schacter, Milena Sant, J. Dik F Habbema, Rengaswamy Sankaranarayanan, Catherine Sutcliffe, Simon Sutcliffe, J. K. Kaijage, P. A. Scanlan, S. Gibson, A. M. Mes-Masson, M. Sawyer, L. Shepherd, P. WatsonB. Zanke, I. A. Small, D. B. Olmedo, M. D. Breitenbach, L. A. Santini, L. A. Maltoni, D. Ramalho, C. G. Ferreira, L. Sharp, S. Cotton, M. Cruickshank, L. Smart, K. Harrild, N. Waugh, J. Little, R. Seth, K. Neal, I. Duncan, A. Ioka, Y. Ito, N. Sato, H. Tsukuma, J. Li, B. N. Zhang, J. H. Fan, Y. L. Qiao, H. Y. Zhong, M. P. Curado, T. J S Pontes, S. Peacock, Jeffrey S Hoch, J. Hoch, Z. Musa, H. K. Weir, C. Friedman, R. German, L. Sharp, A. O. Ceilleachair, H. Comber, L. Tilson, C. Walsh, C. Usher, M. Barry, J. Chilcott, P. Tappenden, S. Whyte, A. Staines, A. Greenberg, L. Fairclough, W. Roberts, D. Masterson Tavares Pereira Ferrera, E. R. Fonseca, L. Casado, M. L. McBride, K. Goddard, M. Lorenzi, J. J. Spinelli, A. M. Broemeling, V. Glickman, S. Pritchard, L. Siegel, P. C. Rogers, S. Sheps, M. A. Annunziata, L. Giovannini, K. Bianchet, B. Muzzatti, M. Berretta, A. Lleshi, U. Tirelli, C. N. Sisimayi, K. Sarwal, H. Torrance, P. Baili, C. Amati, F. Di Salvo, C. Frazzingaro, N. Sanz, A. Micheli

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Comprehensive cancer control is defined as an integrated and coordinated approach to reducing cancer incidence, morbidity, and mortality across the cancer control continuum from primary prevention to end-of-life care. This approach assumes that when the public sector, non-governmental organizations, academia, and the private sector share with each other their skills, knowledge, and resources, a country can take advantage of all its talents and resources to more quickly reduce the burden of cancer for all its population. One critical issue for comprehensive cancer control is the extent to which the private sector can contribute to cancer prevention and control programs and policies that have historically been lead by the public health sector, and similarly how can the public sector increase its investment and involvement in clinical research and practice issues that are largely driven by the private sector worldwide? In addition, building capacity to integrate research that is appropriate to the culture and context of the population will be important in different settings, in particular research related to cancer control interventions that have the capacity to influence outcomes. To whatever extent cancer control research is ultimately funded through the private and public sectors, if investments in research discoveries are ultimately to benefit the populations that bear the greatest burden of disease, then new approaches to integrating the lessons learned from science with the lessons learned from service (public health, clinical, and public policy) must be found to close the gap between what we know and what we do. Communities of practice for international cancer control, like the ones fostered by the first three International Cancer Control Congresses, represent an important forum for knowledge exchange opportunities to accelerate the translation of new knowledge into action to reduce the burden of cancer worldwide.

Original languageEnglish (US)
Pages (from-to)610-622
Number of pages13
JournalTumori
Volume95
Issue number5
StatePublished - Sep 2009
Externally publishedYes

Fingerprint

Research
Private Sector
Neoplasms
Public Sector
Population
Capacity Building
Aptitude
Translational Medical Research
Terminal Care
Primary Prevention
Public Policy
Health Policy
Public Health
Organizations
Morbidity
Mortality
Incidence

Keywords

  • Cancer control
  • ICCC-3
  • International collaboration

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kerner, J. F., Cazap, E., Yach, D., Pierotti, M. A., Daidone, M. G., De Blasio, P., ... Micheli, A. (2009). Comprehensive cancer control-research & development: Knowing what we do and doing what we know. Tumori, 95(5), 610-622.

Comprehensive cancer control-research & development : Knowing what we do and doing what we know. / Kerner, Jon F.; Cazap, Eduardo; Yach, Derek; Pierotti, Marco A.; Daidone, Maria Grazia; De Blasio, Pasquale; Geary, Peter; Schacter, Brent; Sant, Milena; Habbema, J. Dik F; Sankaranarayanan, Rengaswamy; Sutcliffe, Catherine; Sutcliffe, Simon; Kaijage, J. K.; Scanlan, P. A.; Gibson, S.; Mes-Masson, A. M.; Sawyer, M.; Shepherd, L.; Watson, P.; Zanke, B.; Small, I. A.; Olmedo, D. B.; Breitenbach, M. D.; Santini, L. A.; Maltoni, L. A.; Ramalho, D.; Ferreira, C. G.; Sharp, L.; Cotton, S.; Cruickshank, M.; Smart, L.; Harrild, K.; Waugh, N.; Little, J.; Seth, R.; Neal, K.; Duncan, I.; Ioka, A.; Ito, Y.; Sato, N.; Tsukuma, H.; Li, J.; Zhang, B. N.; Fan, J. H.; Qiao, Y. L.; Zhong, H. Y.; Curado, M. P.; Pontes, T. J S; Peacock, S.; Hoch, Jeffrey S; Hoch, J.; Musa, Z.; Weir, H. K.; Friedman, C.; German, R.; Sharp, L.; Ceilleachair, A. O.; Comber, H.; Tilson, L.; Walsh, C.; Usher, C.; Barry, M.; Chilcott, J.; Tappenden, P.; Whyte, S.; Staines, A.; Greenberg, A.; Fairclough, L.; Roberts, W.; Masterson Tavares Pereira Ferrera, D.; Fonseca, E. R.; Casado, L.; McBride, M. L.; Goddard, K.; Lorenzi, M.; Spinelli, J. J.; Broemeling, A. M.; Glickman, V.; Pritchard, S.; Siegel, L.; Rogers, P. C.; Sheps, S.; Annunziata, M. A.; Giovannini, L.; Bianchet, K.; Muzzatti, B.; Berretta, M.; Lleshi, A.; Tirelli, U.; Sisimayi, C. N.; Sarwal, K.; Torrance, H.; Baili, P.; Amati, C.; Di Salvo, F.; Frazzingaro, C.; Sanz, N.; Micheli, A.

In: Tumori, Vol. 95, No. 5, 09.2009, p. 610-622.

Research output: Contribution to journalArticle

Kerner, JF, Cazap, E, Yach, D, Pierotti, MA, Daidone, MG, De Blasio, P, Geary, P, Schacter, B, Sant, M, Habbema, JDF, Sankaranarayanan, R, Sutcliffe, C, Sutcliffe, S, Kaijage, JK, Scanlan, PA, Gibson, S, Mes-Masson, AM, Sawyer, M, Shepherd, L, Watson, P, Zanke, B, Small, IA, Olmedo, DB, Breitenbach, MD, Santini, LA, Maltoni, LA, Ramalho, D, Ferreira, CG, Sharp, L, Cotton, S, Cruickshank, M, Smart, L, Harrild, K, Waugh, N, Little, J, Seth, R, Neal, K, Duncan, I, Ioka, A, Ito, Y, Sato, N, Tsukuma, H, Li, J, Zhang, BN, Fan, JH, Qiao, YL, Zhong, HY, Curado, MP, Pontes, TJS, Peacock, S, Hoch, JS, Hoch, J, Musa, Z, Weir, HK, Friedman, C, German, R, Sharp, L, Ceilleachair, AO, Comber, H, Tilson, L, Walsh, C, Usher, C, Barry, M, Chilcott, J, Tappenden, P, Whyte, S, Staines, A, Greenberg, A, Fairclough, L, Roberts, W, Masterson Tavares Pereira Ferrera, D, Fonseca, ER, Casado, L, McBride, ML, Goddard, K, Lorenzi, M, Spinelli, JJ, Broemeling, AM, Glickman, V, Pritchard, S, Siegel, L, Rogers, PC, Sheps, S, Annunziata, MA, Giovannini, L, Bianchet, K, Muzzatti, B, Berretta, M, Lleshi, A, Tirelli, U, Sisimayi, CN, Sarwal, K, Torrance, H, Baili, P, Amati, C, Di Salvo, F, Frazzingaro, C, Sanz, N & Micheli, A 2009, 'Comprehensive cancer control-research & development: Knowing what we do and doing what we know', Tumori, vol. 95, no. 5, pp. 610-622.
Kerner JF, Cazap E, Yach D, Pierotti MA, Daidone MG, De Blasio P et al. Comprehensive cancer control-research & development: Knowing what we do and doing what we know. Tumori. 2009 Sep;95(5):610-622.
Kerner, Jon F. ; Cazap, Eduardo ; Yach, Derek ; Pierotti, Marco A. ; Daidone, Maria Grazia ; De Blasio, Pasquale ; Geary, Peter ; Schacter, Brent ; Sant, Milena ; Habbema, J. Dik F ; Sankaranarayanan, Rengaswamy ; Sutcliffe, Catherine ; Sutcliffe, Simon ; Kaijage, J. K. ; Scanlan, P. A. ; Gibson, S. ; Mes-Masson, A. M. ; Sawyer, M. ; Shepherd, L. ; Watson, P. ; Zanke, B. ; Small, I. A. ; Olmedo, D. B. ; Breitenbach, M. D. ; Santini, L. A. ; Maltoni, L. A. ; Ramalho, D. ; Ferreira, C. G. ; Sharp, L. ; Cotton, S. ; Cruickshank, M. ; Smart, L. ; Harrild, K. ; Waugh, N. ; Little, J. ; Seth, R. ; Neal, K. ; Duncan, I. ; Ioka, A. ; Ito, Y. ; Sato, N. ; Tsukuma, H. ; Li, J. ; Zhang, B. N. ; Fan, J. H. ; Qiao, Y. L. ; Zhong, H. Y. ; Curado, M. P. ; Pontes, T. J S ; Peacock, S. ; Hoch, Jeffrey S ; Hoch, J. ; Musa, Z. ; Weir, H. K. ; Friedman, C. ; German, R. ; Sharp, L. ; Ceilleachair, A. O. ; Comber, H. ; Tilson, L. ; Walsh, C. ; Usher, C. ; Barry, M. ; Chilcott, J. ; Tappenden, P. ; Whyte, S. ; Staines, A. ; Greenberg, A. ; Fairclough, L. ; Roberts, W. ; Masterson Tavares Pereira Ferrera, D. ; Fonseca, E. R. ; Casado, L. ; McBride, M. L. ; Goddard, K. ; Lorenzi, M. ; Spinelli, J. J. ; Broemeling, A. M. ; Glickman, V. ; Pritchard, S. ; Siegel, L. ; Rogers, P. C. ; Sheps, S. ; Annunziata, M. A. ; Giovannini, L. ; Bianchet, K. ; Muzzatti, B. ; Berretta, M. ; Lleshi, A. ; Tirelli, U. ; Sisimayi, C. N. ; Sarwal, K. ; Torrance, H. ; Baili, P. ; Amati, C. ; Di Salvo, F. ; Frazzingaro, C. ; Sanz, N. ; Micheli, A. / Comprehensive cancer control-research & development : Knowing what we do and doing what we know. In: Tumori. 2009 ; Vol. 95, No. 5. pp. 610-622.
@article{ae2fe3285bdb4e508a97c753ad3b1fde,
title = "Comprehensive cancer control-research & development: Knowing what we do and doing what we know",
abstract = "Comprehensive cancer control is defined as an integrated and coordinated approach to reducing cancer incidence, morbidity, and mortality across the cancer control continuum from primary prevention to end-of-life care. This approach assumes that when the public sector, non-governmental organizations, academia, and the private sector share with each other their skills, knowledge, and resources, a country can take advantage of all its talents and resources to more quickly reduce the burden of cancer for all its population. One critical issue for comprehensive cancer control is the extent to which the private sector can contribute to cancer prevention and control programs and policies that have historically been lead by the public health sector, and similarly how can the public sector increase its investment and involvement in clinical research and practice issues that are largely driven by the private sector worldwide? In addition, building capacity to integrate research that is appropriate to the culture and context of the population will be important in different settings, in particular research related to cancer control interventions that have the capacity to influence outcomes. To whatever extent cancer control research is ultimately funded through the private and public sectors, if investments in research discoveries are ultimately to benefit the populations that bear the greatest burden of disease, then new approaches to integrating the lessons learned from science with the lessons learned from service (public health, clinical, and public policy) must be found to close the gap between what we know and what we do. Communities of practice for international cancer control, like the ones fostered by the first three International Cancer Control Congresses, represent an important forum for knowledge exchange opportunities to accelerate the translation of new knowledge into action to reduce the burden of cancer worldwide.",
keywords = "Cancer control, ICCC-3, International collaboration",
author = "Kerner, {Jon F.} and Eduardo Cazap and Derek Yach and Pierotti, {Marco A.} and Daidone, {Maria Grazia} and {De Blasio}, Pasquale and Peter Geary and Brent Schacter and Milena Sant and Habbema, {J. Dik F} and Rengaswamy Sankaranarayanan and Catherine Sutcliffe and Simon Sutcliffe and Kaijage, {J. K.} and Scanlan, {P. A.} and S. Gibson and Mes-Masson, {A. M.} and M. Sawyer and L. Shepherd and P. Watson and B. Zanke and Small, {I. A.} and Olmedo, {D. B.} and Breitenbach, {M. D.} and Santini, {L. A.} and Maltoni, {L. A.} and D. Ramalho and Ferreira, {C. G.} and L. Sharp and S. Cotton and M. Cruickshank and L. Smart and K. Harrild and N. Waugh and J. Little and R. Seth and K. Neal and I. Duncan and A. Ioka and Y. Ito and N. Sato and H. Tsukuma and J. Li and Zhang, {B. N.} and Fan, {J. H.} and Qiao, {Y. L.} and Zhong, {H. Y.} and Curado, {M. P.} and Pontes, {T. J S} and S. Peacock and Hoch, {Jeffrey S} and J. Hoch and Z. Musa and Weir, {H. K.} and C. Friedman and R. German and L. Sharp and Ceilleachair, {A. O.} and H. Comber and L. Tilson and C. Walsh and C. Usher and M. Barry and J. Chilcott and P. Tappenden and S. Whyte and A. Staines and A. Greenberg and L. Fairclough and W. Roberts and {Masterson Tavares Pereira Ferrera}, D. and Fonseca, {E. R.} and L. Casado and McBride, {M. L.} and K. Goddard and M. Lorenzi and Spinelli, {J. J.} and Broemeling, {A. M.} and V. Glickman and S. Pritchard and L. Siegel and Rogers, {P. C.} and S. Sheps and Annunziata, {M. A.} and L. Giovannini and K. Bianchet and B. Muzzatti and M. Berretta and A. Lleshi and U. Tirelli and Sisimayi, {C. N.} and K. Sarwal and H. Torrance and P. Baili and C. Amati and {Di Salvo}, F. and C. Frazzingaro and N. Sanz and A. Micheli",
year = "2009",
month = "9",
language = "English (US)",
volume = "95",
pages = "610--622",
journal = "Tumori",
issn = "0300-8916",
publisher = "Wichtig Publishing",
number = "5",

}

TY - JOUR

T1 - Comprehensive cancer control-research & development

T2 - Knowing what we do and doing what we know

AU - Kerner, Jon F.

AU - Cazap, Eduardo

AU - Yach, Derek

AU - Pierotti, Marco A.

AU - Daidone, Maria Grazia

AU - De Blasio, Pasquale

AU - Geary, Peter

AU - Schacter, Brent

AU - Sant, Milena

AU - Habbema, J. Dik F

AU - Sankaranarayanan, Rengaswamy

AU - Sutcliffe, Catherine

AU - Sutcliffe, Simon

AU - Kaijage, J. K.

AU - Scanlan, P. A.

AU - Gibson, S.

AU - Mes-Masson, A. M.

AU - Sawyer, M.

AU - Shepherd, L.

AU - Watson, P.

AU - Zanke, B.

AU - Small, I. A.

AU - Olmedo, D. B.

AU - Breitenbach, M. D.

AU - Santini, L. A.

AU - Maltoni, L. A.

AU - Ramalho, D.

AU - Ferreira, C. G.

AU - Sharp, L.

AU - Cotton, S.

AU - Cruickshank, M.

AU - Smart, L.

AU - Harrild, K.

AU - Waugh, N.

AU - Little, J.

AU - Seth, R.

AU - Neal, K.

AU - Duncan, I.

AU - Ioka, A.

AU - Ito, Y.

AU - Sato, N.

AU - Tsukuma, H.

AU - Li, J.

AU - Zhang, B. N.

AU - Fan, J. H.

AU - Qiao, Y. L.

AU - Zhong, H. Y.

AU - Curado, M. P.

AU - Pontes, T. J S

AU - Peacock, S.

AU - Hoch, Jeffrey S

AU - Hoch, J.

AU - Musa, Z.

AU - Weir, H. K.

AU - Friedman, C.

AU - German, R.

AU - Sharp, L.

AU - Ceilleachair, A. O.

AU - Comber, H.

AU - Tilson, L.

AU - Walsh, C.

AU - Usher, C.

AU - Barry, M.

AU - Chilcott, J.

AU - Tappenden, P.

AU - Whyte, S.

AU - Staines, A.

AU - Greenberg, A.

AU - Fairclough, L.

AU - Roberts, W.

AU - Masterson Tavares Pereira Ferrera, D.

AU - Fonseca, E. R.

AU - Casado, L.

AU - McBride, M. L.

AU - Goddard, K.

AU - Lorenzi, M.

AU - Spinelli, J. J.

AU - Broemeling, A. M.

AU - Glickman, V.

AU - Pritchard, S.

AU - Siegel, L.

AU - Rogers, P. C.

AU - Sheps, S.

AU - Annunziata, M. A.

AU - Giovannini, L.

AU - Bianchet, K.

AU - Muzzatti, B.

AU - Berretta, M.

AU - Lleshi, A.

AU - Tirelli, U.

AU - Sisimayi, C. N.

AU - Sarwal, K.

AU - Torrance, H.

AU - Baili, P.

AU - Amati, C.

AU - Di Salvo, F.

AU - Frazzingaro, C.

AU - Sanz, N.

AU - Micheli, A.

PY - 2009/9

Y1 - 2009/9

N2 - Comprehensive cancer control is defined as an integrated and coordinated approach to reducing cancer incidence, morbidity, and mortality across the cancer control continuum from primary prevention to end-of-life care. This approach assumes that when the public sector, non-governmental organizations, academia, and the private sector share with each other their skills, knowledge, and resources, a country can take advantage of all its talents and resources to more quickly reduce the burden of cancer for all its population. One critical issue for comprehensive cancer control is the extent to which the private sector can contribute to cancer prevention and control programs and policies that have historically been lead by the public health sector, and similarly how can the public sector increase its investment and involvement in clinical research and practice issues that are largely driven by the private sector worldwide? In addition, building capacity to integrate research that is appropriate to the culture and context of the population will be important in different settings, in particular research related to cancer control interventions that have the capacity to influence outcomes. To whatever extent cancer control research is ultimately funded through the private and public sectors, if investments in research discoveries are ultimately to benefit the populations that bear the greatest burden of disease, then new approaches to integrating the lessons learned from science with the lessons learned from service (public health, clinical, and public policy) must be found to close the gap between what we know and what we do. Communities of practice for international cancer control, like the ones fostered by the first three International Cancer Control Congresses, represent an important forum for knowledge exchange opportunities to accelerate the translation of new knowledge into action to reduce the burden of cancer worldwide.

AB - Comprehensive cancer control is defined as an integrated and coordinated approach to reducing cancer incidence, morbidity, and mortality across the cancer control continuum from primary prevention to end-of-life care. This approach assumes that when the public sector, non-governmental organizations, academia, and the private sector share with each other their skills, knowledge, and resources, a country can take advantage of all its talents and resources to more quickly reduce the burden of cancer for all its population. One critical issue for comprehensive cancer control is the extent to which the private sector can contribute to cancer prevention and control programs and policies that have historically been lead by the public health sector, and similarly how can the public sector increase its investment and involvement in clinical research and practice issues that are largely driven by the private sector worldwide? In addition, building capacity to integrate research that is appropriate to the culture and context of the population will be important in different settings, in particular research related to cancer control interventions that have the capacity to influence outcomes. To whatever extent cancer control research is ultimately funded through the private and public sectors, if investments in research discoveries are ultimately to benefit the populations that bear the greatest burden of disease, then new approaches to integrating the lessons learned from science with the lessons learned from service (public health, clinical, and public policy) must be found to close the gap between what we know and what we do. Communities of practice for international cancer control, like the ones fostered by the first three International Cancer Control Congresses, represent an important forum for knowledge exchange opportunities to accelerate the translation of new knowledge into action to reduce the burden of cancer worldwide.

KW - Cancer control

KW - ICCC-3

KW - International collaboration

UR - http://www.scopus.com/inward/record.url?scp=70849089699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70849089699&partnerID=8YFLogxK

M3 - Article

C2 - 19999951

AN - SCOPUS:70849089699

VL - 95

SP - 610

EP - 622

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 5

ER -